SA
SNPS icon

Strategic Advocates’s Synopsys SNPS Stock Holding History

Strategic Advocates’s Portfolio SNPS Stock Details SNPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.98K Sell
5
-395
-99% -$179K 0.01% 215
2025
Q4 		$190K Sell
400
-16
-4% -$7.11K 0.05% 119
2025
Q3 		$205K Sell
416
-29
-7% -$16.4K 0.05% 126
2025
Q2 		$228K Buy
+445
New +$207K 0.07% 115
2025
Q1 		– Sell
-4,088
Closed -$1.98M – 127
2024
Q4 		$1.98M Sell
4,088
-304
-7% -$159K 0.67% 26
2024
Q3 		$2.22M Sell
4,392
-1,078
-20% -$578K 0.8% 23
2024
Q2 		$3.25M Buy
5,470
+788
+17% +$446K 1.29% 16
2024
Q1 		$2.68M Buy
+4,682
New +$2.58M 1.03% 23

Other funds holding SNPS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NC
Nvidia Corp Santa Clara, California $18.4B AUM 362.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Strategic Advocates's SNPS Position: Q1 2026 in Review

Strategic Advocates reduced its Synopsys (SNPS) stake by 99% in Q1 2026, selling an estimated $179K and leaving 5 shares worth $1.98K. The position accounts for 0.01% of the portfolio, ranked #215.

Strategic Advocates first reported a position in SNPS in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.25M in Q2 2024. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Strategic Advocates held 5 shares of Synopsys worth $1.98K as of Q1 2026.
  • Strategic Advocates sold 395 Synopsys shares in Q1 2026, an estimated $179K.
  • Synopsys made up 0.01% of Strategic Advocates's portfolio in Q1 2026, its #215 holding.
  • Strategic Advocates first reported a position in Synopsys in Q1 2024 and has held it in 8 quarters since.
  • Strategic Advocates's Synopsys position peaked at $3.25M in Q2 2024.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.